WELCOME. Taking Care of Your Health. April 30, 8 am to noon

Similar documents
Importance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC

Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary?

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

Objectives. Case Study #1 1/28/14. A Collaborative Practice Approach to Genetic Testing in Cancer: Translating Science Into Clinical Practice

Primary Care Approach to Genetic Cancer Syndromes

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

Does Cancer Run in Your Family?

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

HBOC. Jessica M. Salamone, ScM, CGC

Genetic Testing: who, what, why?

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

Does Cancer Run in Your Family?

The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice

Genetic Risk Assessment for Cancer

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Cancer Genomics 101. BCCCP 2015 Annual Meeting

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

HEREDITARY CANCER SYNDROMES: IDENTIFYING THOSE AT RISK

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

11/29/2017. Genetics and Cancer ERICA L SILVER, MS, LCGC GENETIC COUNSELOR. Genetics 101. Transcription vs Translation

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Hereditary Cancer Update: What do GPOs need to know?

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES

BRCAnowTM It s Your Decision

Genetic Determinants, Risk Assessment and Management

The Next Generation of Hereditary Cancer Testing

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

A guide to genetic testing for hereditary cancers

Lynch Syndrome. Angie Strang, PGY2

Outline. Identifying your risk for hereditary breast or ovarian cancer. Genetics 101. What causes cancer? Genetics

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

Universal Screening for Lynch Syndrome

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

AllinaHealthSystems 1

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention

Genetic Risk Assessment for Cancer

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center

Hereditary Gynecologic Cancer

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

WHAT DO GENES HAVE TO DO WITH IT? Breast Cancer Risk Assessment and Risk Reduction in 2016

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

Result Navigator Positive Test Result: MSH6

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

Hereditary Aspects of Pancreatic Cancer

OBJECTIVES 8/25/2017. An attempt to organize the chaos

Precision Medicine and Genetic Counseling : Is Yes always the correct answer?


Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

Hereditary Breast and Ovarian Cancer Screening & Genetic Counseling

Unique Aspects of Breast Cancer in African American Women: TRIPLE NEGATIVE BREAST CANCER

patient education Fact Sheet

Lori Carpenter, MS, LCGC Saint Francis Hospital

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

Cancer statistics (US)

Genetic Screening Visit

Advice about familial aspects of breast cancer and epithelial ovarian cancer

Cancer - the Beginning: Biology, Pathology and Genetic Predisposition

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Understanding and Managing Lynch Syndrome

Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center

Why Test for Hereditary Cancer in Preventive Care?

GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention

Tumori eredofamiliari: sorveglianza di donne ad alto rischio

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

The Importance of Iden0fying Women at Risk for BRCA1/2 Muta0ons for Referral to Cancer Gene0cs Services

Genetics of Pancreatic Cancer. October 6, If you experience technical difficulty during the presentation:

Introduction to Evaluating Hereditary Risk. Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center

Approximately 5% to 10% of breast cancer (BC) is hereditary in nature. Since. By Dawna Gilchrist, MD, FRCPC, FCCMG

Familial and Hereditary Colon Cancer

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY

A Review from the Genetic Counselor s Perspective

ProstateGene What is hereditary prostate cancer? What are genes?

MSH6 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MSH6 Summary Cancer Risk Table

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

Hereditary breast cancer who to refer to a cancer genetics clinic and how to counsel patients with

Genetic Testing for BRCA1 and BRCA2 Genes

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

POSITIVE DELETERIOUS MUTATION

Transcription:

WELCOME Taking Care of Your Health April 30, 8 am to noon

Cancer: Know Your Risk Emily Kuchinsky, MS, CGC, Certified Genetic Counselor

Sporadic Cancer

Lifetime Probability- Women

Family Cluster

Risk factors for breast cancer May 5, 2016 6

Hereditary Cancer Br 45 5-10% of all cancer Young age of onset Bilateral or more than one cancer Cancer in many generations

5-10% of Breast Cancer is Inherited

BRCA 1 and 2 The names BRCA1 and BRCA2 stand for breast cancer susceptibility gene 1 and breast cancer susceptibility gene 2, respectively. Breast Cancer

Genetic Mutations May 5, 2016 11

Earlier Age of Cancer Onset in Hereditary Cancer Cancer May 5, 2016 12

Autosomal Dominant Inheritance If parent carries mutation, each of their children would have a 50% chance to inherit the same mutation

BRCA1-Associated Cancers: Lifetime Risk Breast cancer 50%-85% (often early age at onset) Second primary breast cancer 40%-60% Ovarian cancer 15%-45% Possible increased risk of other cancers (eg: prostate)

BRCA2-Associated Cancers: Lifetime Risk breast cancer (40%-85%) ovarian cancer (10%-25%) male breast cancer (5-7%) Increased risk of prostate, melanoma, and pancreatic cancers (magnitude unknown)

Red Flags for Hereditary Breast and Ovarian Cancer Syndrome Breast Cancer prior to age 50 or premenopausal 2 or more family members with breast and/or ovarian cancer Personal History of Ovarian Cancer Personal History of breast cancer in both breasts or a second breast cancer Triple Negative Breast Cancer Male Breast Cancer Ashkenazi Jewish ancestry Pancreatic Cancer along with Breast Cancer

Surveillance for Female BRCA Breast Cancer Surveillance Ovarian Cancer surveillance Carriers Procedure Age to Begin Frequency Breast self-exam training Clinical breast exam 18 yrs 25 yrs Every 6-12 months Mammography 25 yrs Yearly MRI 25 yrs Yearly Pelvic exam TVUS and CA-125 35 yrs in patients not electing RRBSO 35 years in patients not electing RRBSO Every 6 months Every 6 months May 5, 2016 18

Beyond BRCA1/2 www.mayo.edu

Change in Testing Paradigm 2012 Next Generation Screening/Launch of Cancer Panels 2013 Angelina Jolie disclosed BRCA status 2013 Supreme Court Decision

Benefits and Limitations of Panel Testing Benefits Cost One sample submission Higher likelihood of receiving positive result Possible Change in Medical Management Incidental Findings Limitations Lack of data on risk-benefit ratio for moderate penetrance genes Higher likelihood of receiving VUS Longer TAT

Family History Suggestive of HNPCC dx. 65 dx. 55 dx. 62 dx. 49 Colon dx. 42 Endometrial

Immunohistochemistry Identify MMR proteins Normally present If protein is absent, gene is not being expressed (mutation or methylation) Helps direct gene testing by predicting likely involved gene MLH1/PMS2 MSH2/MSH6 MLH1 MSH2 PMS2 MSH6 Courtesy H. Hampel

Germline MLH1 mutation MLH1 MSH2

Screening and Management Increased frequency of colonoscopy Every 1-2 years beginning in the 20s May consider : at physician s discretion due to lack of known efficacy: Annual transvaginal ultrasound Annual Endometrial biopsy CA-125 blood test Patient education NCCN 2012

Screening and Management, May consider: con d EGD for gastric and small bowel cancers, beginning in 30s, every 3-5 yrs Urinalysis, beginning at 25yr Annual physical exam NCCN 2015

Genetic Consult Detailed Family History Discuss benefits and limitations of genetic testing Sample collection Results discussion

Testing may: Clarify the risk for cancer Provide options for medical management Have implications for family members

GINA Genetic Information Nondiscrimination Act of 2008 (GINA) Covers: health insurers and employers Does NOT cover: life insurance, disability insurance and long-term care insurance

Options for Individuals with Mutations Positive test result Increased cancer screening Non-surgical prevention Risk-reducing surgery

Limitations of Testing Does not detect all mutations; may not rule out hereditary risk Effectiveness of some early detection measures is not proven Continued risk of sporadic cancer

How to decide about being tested How/if would use the information Speak with family Identify best person to test first Check on insurance coverage

Summary Cancer is a complex disease Some risk factors we cannot change Many risk factors can be reduced The more you know about your risks, the more you can take control of your health Know your family history Discuss your cancer risks with your doctor!

Contact Information Emily Kuchinsky, MS 443-777-7656 Emily.Kuchinsky@medstar.net May 5, 2016 37